GL1X · GenesisL1 explorer

Research workbench

Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody

Analyse Crystal structure of HIV-1 primary receptor CD4 in complex with a potent… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3O2D
Type
protein
Length
616 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ibalizumab light chain; Ibalizumab heavy chain; T-cell surface glycoprotein CD4
UniProt
P01730
Pockets
7 · best druggability 0.64

Structure

x-ray diffraction · 3 distinct chains · 8% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LIbalizumab light chainprotein2166% helix, 53% strand—
HIbalizumab heavy chainprotein2228% helix, 52% strand—
AT-cell surface glycoprotein CD4protein1788% helix, 53% strandP01730

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16650.640.7468empty
21250.530.8124empty
31230.520.8120empty
4640.510.8615empty
5830.420.7921empty

Interfaces

3 interfaces between chains.

  • L–H · 1854 Ų buried · 19 hydrogen bonds · protein-protein
  • H–A · 752 Ų buried · 12 hydrogen bonds · protein-protein
  • L–A · 565 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 3O2D · Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral… · the same entry in another collection · chain L against L, TM-score 1.00
  • P01730 · AlphaFold monomer V2.0 prediction for T-cell surface glycoprotein CD4 (P01730) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.